DetailedAnalysis of the CD8 + T-Cell Response followingAdenovirusVaccination
Author:
Affiliation:
1. Center for Gene Therapeutics, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario L8N 3Z5, Canada
Abstract
Publisher
American Society for Microbiology
Subject
Virology,Insect Science,Immunology,Microbiology
Link
https://journals.asm.org/doi/pdf/10.1128/JVI.77.24.13407-13411.2003
Reference22 articles.
1. Andersen, H., D. Dempsey, R. Chervenak, and S. R. Jennings. 2000 . Expression of intracellular IFN-gamma in HSV-1-specific CD8+ T cells identifies distinct responding subpopulations during the primary response to infection.J. Immunol.165:2101-2107.
2. Babiuk, L. A., and S. K. Tikoo. 2000. Adenoviruses as vectors for delivering vaccines to mucosal surfaces.J. Biotechnol.83:105-113.
3. Badovinac, V. P., B. B. Porter, and J. T. Harty. 2002 . Programmed contraction of CD8(+) T cells after infection. Nat. Immunol.3:619-626.
4. Bertram, E. M., A. Tafuri, A. Shahinian, V. S. Chan, L. Hunziker, M. Recher, P. S. Ohashi, T. W. Mak, and T. H. Watts. 2002. Role of ICOS versus CD28 in antiviral immunity. Eur. J. Immunol.32:3376-3385.
5. Chan, S. Y., K. Li, J. R. Piccotti, M. C. Louie, T. A. Judge, L. A. Turka, E. J. Eichwald, and D. K. Bishop. 1999. Tissue-specific consequences of the anti-adenoviral immune response: implications for cardiac transplants. Nat. Med.5:1143-1149.
Cited by 65 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma;npj Vaccines;2023-08-04
2. Dissecting the Protective Effect of CD8+ T Cells in Response to SARS-CoV-2 mRNA Vaccination and the Potential Link with Lymph Node CD8+ T Cells;Biology;2023-07-22
3. Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression in vivo;Frontiers in Immunology;2023-02-23
4. Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity;European Journal of Immunology;2022-11-20
5. A phase I study of an adenoviral vector delivering a MUC1/CD40-ligand fusion protein in patients with advanced adenocarcinoma;Nature Communications;2022-10-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3